Metrikler
Yayın
222
Açık Erişim
54
BM Sürdürülebilir Kalkınma Amaçları
Eğitim Bilgileri
2000 - 2000
2000 - 2000Tıpta Yandal Uzmanlık
Hacettepe Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Türkiye
2000 - 2000
2000 - 2000Tıpta Yandal Uzmanlık
Hacettepe Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Türkiye
1996 - 1999
1996 - 1999Tıpta Yandal Uzmanlık
Duke University, Onkoloji Ve Kemik İliği Nakli, Amerika Birleşik Devletleri
1996 - 1999
1996 - 1999Tıpta Yandal Uzmanlık
University of Illinois at Chicago, Hematoloji Ve Onkoloji, Amerika Birleşik Devletleri
1988 - 1992
1988 - 1992Tıpta Uzmanlık
Hacettepe Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Türkiye
Yabancı Diller
C1 İleri
C1 İleriİngilizce
Araştırma Alanları
Sağlık Bilimleri
Akademik Faaliyetlere Dayalı Araştırma Alanları
Avesis Araştırma Alanları
WoS Araştırma Alanları
Scopus Araştırma Alanları
Akademik Ünvanlar / Görevler
2009 - Devam Ediyor
2009 - Devam EdiyorProf. Dr.
Hacettepe Üniversitesi, Tıp Fakültesi (Türkçe), Dahili Tıp Bilimleri Bölümü
2003 - 2009
2003 - 2009Doç. Dr.
Hacettepe Üniversitesi, Tıp Fakültesi (İngilizce), Dahili Tıp Bilimleri Bölümü
2000 - 2003
2000 - 2003Öğretim Görevlisi
Hacettepe Üniversitesi, Tıp Fakültesi (İngilizce), Dahili Tıp Bilimleri Bölümü
Yönetimsel Görevler
2013 - 2015
2013 - 2015Anabilim/Bilim Dalı Başkanı
Hacettepe Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
Makaleler
Tümü (159)
SCI-E, SSCI, AHCI (149)
SCI-E, SSCI, AHCI, ESCI (157)
ESCI (8)
Scopus (150)
TRDizin (52)
2025
20251. Anemia in the patients with acute myeloid leukemia revisited: Prognostic importance of anemia on treatment-naïve patients
Çınar O. E., Malkan U. Y., Aladag E., Demiroglu H., Büyükaşık Y., Göker H., et al.
Acta Medica
, cilt.56, sa.2, ss.116-121, 2025 (TRDizin)
2025
20252. Turkish translation, validity, and reliability of the European organization for research and treatment of cancer quality of life-high dose chemotherapy29 in patients undergone hematopoietic stem cell transplantation
Kabak V. Y., Karahan S., Aladag E., Duger T., Uysal S. A., Erdem F. I., et al.
Turkish Journal of Medical Sciences
, cilt.55, sa.3, ss.540-546, 2025 (SCI-Expanded, Scopus, TRDizin)
2025
20253. Long-Term Outcomes of Allogeneic Stem Cell Transplantation for Relapsed/Refractory Hodgkin and Non-Hodgkin Lymphoma: Multi-center Experience from Turkey
Uysal A., SOYER N., Ozdogu H., GÖKER H., ÇINAR O. E., Deveci B., et al.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION
, sa.1, ss.43-52, 2025 (SCI-Expanded, Scopus)
2024
20244. DOES THE PRESENCE OF ANEMIA HAVE AN IMPACT ON PHYSICAL FUNCTIONS IN PATIENTS TREATED WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION?
YILDIZ KABAK V., ATASAVUN UYSAL S., ALADAĞ KARAKULAK E., GÖKER H., DÜGER T.
TURKISH JOURNAL OF PHYSIOTHERAPY REHABILITATION-TURK FIZYOTERAPI VE REHABILITASYON DERGISI
, cilt.35, sa.3, ss.290-296, 2024 (ESCI, TRDizin)
2023
20235. Exploring the distribution and prognostic effect of the ABO blood types of COVID-19 patients during delta and omicron waves: A case control study
GÖKER H., ÇINAR O. E., ISMAYILOV R., Özdemir E., MALKAN Ü. Y., ALADAĞ E., et al.
Acta Medica
, cilt.54, sa.2, ss.97-102, 2023 (Hakemli Dergi)
2023
20236. Asymptomatic unilateral phrenic nerve palsy after bortezomib treatment in a newly diagnosed multiple myeloma patient
Coskunpinar M., Erdogdu B., GÖKER H.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE
, cilt.29, sa.2, ss.502-505, 2023 (SCI-Expanded, Scopus)
2023
20237. Hypophosphatemia related to the use of ibrutinib
KARADENİZ M., ÇINAR O. E., Erdogdu B., MALKAN Ü. Y., GÖKER H., ÖZCEBE O. İ.
Journal of Oncology Pharmacy Practice
, 2023 (SCI-Expanded, Scopus)
2023
20238. A single-center experience of haploidentical stem cell transplantation in hematological malignancies
MALKAN Ü. Y., GÖKER H., DEMİROĞLU H., Tekin F., Akdemir B., ALADAĞ KARAKULAK E., et al.
Turkish Journal of Medical Sciences
, cilt.53, sa.1, ss.352-359, 2023 (SCI-Expanded, Scopus, TRDizin)
2022
20229. Comment on Zamfir et al. Hematologic Malignancies Diagnosed in the Context of the mRNA COVID-19 Vaccination Campaign: A Report of Two Cases. Medicina 2022, 58, 874
ÇINAR O. E., Erdogdu B., KARADENİZ M., ÜNAL S., MALKAN Ü. Y., GÖKER H., et al.
MEDICINA-LITHUANIA
, cilt.58, sa.11, 2022 (SCI-Expanded, Scopus)
2022
202210. Validity and reliability of the Turkish version of the functional assessment of cancer therapy-bone marrow transplant (FACT-BMT) quality of life questionnaire in patients undergoing bone marrow transplantation
YILDIZ KABAK V., Demircioglu A., Aladag E., KARAHAN S., GÖKER H., ATASAVUN UYSAL S., et al.
Palliative and Supportive Care
, cilt.20, sa.4, ss.556-563, 2022 (SSCI, Scopus)
2022
202211. Hepatitis E Virus Prevalence and Associated Risk Factors in High-Risk Groups: A Cross-Sectional Study
BALABAN H. Y., ASLAN A. T., AKDOĞAN KITTANA F. N., ALP A., DAĞ O., AYAR Ş. N., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, cilt.33, sa.7, ss.615-624, 2022 (SCI-Expanded, Scopus, TRDizin)
2022
202212. Prospective registry of adult patients receiving therapeutic plasma exchange with a presumptive diagnosis of thrombotic microangiopathy (TMA): The Turkish hematology research and education group (ThREG)-TMA02 study
Akpinar S., Tekgunduz E., Esen R., YILMAZ M., Karakus V., VURAL F., et al.
TRANSFUSION AND APHERESIS SCIENCE
, cilt.61, sa.1, 2022 (SCI-Expanded, Scopus)
2022
202213. Covid-19 Related Fatality and Risk Factors in Multiple Myeloma: A Multicenter Cohort Study
KARADENİZ M., GÖKER H., Aydin O., Turgut M., MALKAN Ü. Y., Sener E., et al.
UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi
, cilt.32, sa.4, ss.209-213, 2022 (SCI-Expanded, Scopus, TRDizin)
2022
202214. Hematopoietic Adverse Events Associated with BNT162b2 mRNA Covid-19 Vaccine
Erdogdu B., ÇINAR O. E., Malkan Ü. Y., AKSU S., DEMİROĞLU H., BÜYÜKAŞIK Y., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.32, sa.1, ss.65-67, 2022 (SCI-Expanded, Scopus, TRDizin)
2022
202215. Efficacy of eltrombopag in thrombocytopenia after hematopoietic stem celltransplantation
KARATAŞ A., GÖKER H., DEMİROĞLU H., MALKAN Ü. Y., Velet M., ÇINAR O. E., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.52, sa.2, ss.413-419, 2022 (SCI-Expanded, Scopus, TRDizin)
2021
202116. Long-term results of allogeneic peripheral blood hematopoietic stem cell transplantation for severe aplastic anemia
ALADAĞ KARAKULAK E., GÖKER H., DEMİROĞLU H., AKSU S., SAYINALP N., HAZNEDAROĞLU İ. C., et al.
TRANSFUSION AND APHERESIS SCIENCE
, cilt.60, sa.2, 2021 (SCI-Expanded, Scopus)
2021
202117. Four-Dimensional Echocardiographic Evaluation of Left Ventricular Systolic Functions in Patients with Chronic Myeloid Leukaemia Receiving Tyrosine Kinase Inhibitors
KARAKULAK U. N., ALADAĞ KARAKULAK E., HEKİMSOY V., ŞAHİNER M. L., KAYA E. B., ÖZER N., et al.
CARDIOVASCULAR TOXICOLOGY
, cilt.21, sa.3, ss.216-223, 2021 (SCI-Expanded, Scopus)
2021
202118. Allogeneic Hematopoietic Stem-Cell Transplantation Improves Disease-Free Survival Compared to Pediatric-Inspired Berlin-Frankfurt-Munster Chemotherapy in Adult Acute Lymphoblastic Leukemia
ALADAĞ KARAKULAK E., Aktimur S. H., Aydin O., DEMİROĞLU H., BÜYÜKAŞIK Y., AKSU S., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
, cilt.21, sa.3, ss.147-153, 2021 (SCI-Expanded, Scopus)
2021
202119. Prediction of Stem Cell Mobilization Failure in Patients with Hodgkin and Non-Hodgkin Lymphoma
DEMİROĞLU H., Ciftciler R., BÜYÜKAŞIK Y., GÖKER H.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.38, sa.3, ss.204-210, 2021 (SCI-Expanded, Scopus, TRDizin)
2021
202120. Central nervous system involvement in patients with acute myeloid leukemia
YAŞAR H. A., ÇINAR O. E., Koylu N. Y., BARIŞTA İ., GÖKER H., BÜYÜKAŞIK Y.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.51, sa.5, ss.2351-2356, 2021 (SCI-Expanded, Scopus, TRDizin)
2021
202121. Comparison of single and double autologous stem cell transplantation in multiple myeloma patients
Malkan Ü. Y., DEMİROĞLU H., BÜYÜKAŞIK Y., KARATAŞ A., ALADAĞ KARAKULAK E., GÖKER H.
OPEN MEDICINE
, cilt.16, sa.1, ss.192-197, 2021 (SCI-Expanded, Scopus)
2021
202122. Effect of Salvage Chemotherapy Before Donor Lymphocyte Infusion in Patients With Relapse After Allogeneic Hematologic Stem Cell Transplantation
ALADAĞ KARAKULAK E., GÖKER H., BÜYÜKAŞIK Y., DEMİROĞLU H.
TRANSPLANTATION PROCEEDINGS
, cilt.53, sa.1, ss.391-395, 2021 (SCI-Expanded, Scopus)
2021
202123. Assessment of ST2 and Reg3a levels in patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
ALADAĞ KARAKULAK E., DEMİROĞLU H., Malkan Ü. Y., Akman U., GÖKER H., BÜYÜKAŞIK Y.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.51, sa.1, ss.355-358, 2021 (SCI-Expanded, Scopus, TRDizin)
2021
202124. Comparison of Risk Scoring Systems in HLA-Matched Related Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study
ALADAĞ KARAKULAK E., DEMİROĞLU H., BÜYÜKAŞIK Y., GÖKER H.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.38, sa.2, ss.138-144, 2021 (SCI-Expanded, Scopus, TRDizin)
2021
202125. Evaluation of Prognostic Significance of the International Staging System According to Glomerular Filtration Rate in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation
Ciftciler R., GÖKER H., DEMİROĞLU H., HAZNEDAROĞLU İ. C., SAYINALP N., AKSU S., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.38, sa.1, ss.33-40, 2021 (SCI-Expanded, Scopus, TRDizin)
2021
202126. Hematopoietic Stem Cell Transplantation for Patients with Paroxysmal Nocturnal Hemoglobinuria with or without Aplastic Anemia: A Multicenter Turkish Experience
Yilmaz F., SOYER N., Seval G. C., Bozdag S. C., TOPÇUOĞLU P., ÜNAL A., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.38, sa.3, ss.195-203, 2021 (SCI-Expanded, Scopus, TRDizin)
2020
202027. Effects of partly supervised and home-based exercise program in patients undergoing hematopoietic stem cell transplantation: a case-control study
YILDIZ KABAK V., GÖKER H., DÜGER T.
SUPPORTIVE CARE IN CANCER
, cilt.28, sa.12, ss.5851-5860, 2020 (SCI-Expanded, Scopus)
2020
202028. Prolonged viral shedding in a lymphoma patient with COVID-19 infection receiving convalescent plasma
KARATAŞ A., İNKAYA A. Ç., DEMİROĞLU H., AKSU S., Haziyev T., ÇINAR O. E., et al.
Transfusion and Apheresis Science
, cilt.59, sa.5, 2020 (SCI-Expanded, Scopus)
2020
202029. Early Access Program Results From Turkey and a Literature Review on Daratumumab Monotherapy Among Heavily Pretreated Patients With Relapsed/Refractory Myeloma
BEKSAÇ M., Aydin Y., GÖKER H., Turgut M., Besisik S. K., Cagirgan S., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
, cilt.20, sa.8, 2020 (SCI-Expanded, Scopus)
2020
202030. Incidence and risk factors for hepatic sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: A retrospective multicenter study of Turkish hematology research and education group (ThREG)
SOYER N., Gunduz M., Tekgunduz E., Deveci B., Ozdogu H., ŞAHİN H. H., et al.
TRANSFUSION AND APHERESIS SCIENCE
, cilt.59, sa.4, 2020 (SCI-Expanded, Scopus)
2020
202031. Cardiac adverse events during stem cell transplantation for hematological malignancies: A single centre experience
ALADAĞ KARAKULAK E., DEMİROĞLU H., BÜYÜKAŞIK Y., KARAKULAK U. N., Tekin F., AKSU S., et al.
TRANSFUSION AND APHERESIS SCIENCE
, cilt.59, sa.2, 2020 (SCI-Expanded, Scopus)
2020
202032. Richter's transformation in patients with chronic lymphocytic leukemia: a cohort study about risk factors
OKAY M., GÜNEŞ G., Malkan Ü. Y., Heziyev T., GÖKER H., HAZNEDAROĞLU İ. C., et al.
LEUKEMIA & LYMPHOMA
, cilt.61, ss.50-52, 2020 (SCI-Expanded, Scopus)
2020
202033. Predictive factors for stem cell mobilization failure in multiple myeloma patients: A single center experience
GÖKER H., Ciftciler R., DEMİROĞLU H., Turgut M., SAYINALP N., Haznedaroglu I. C., et al.
TRANSFUSION AND APHERESIS SCIENCE
, cilt.59, sa.1, 2020 (SCI-Expanded, Scopus)
2020
202034. The experience of allogeneic hematopoietic stem cell transplantation in a patient with X-linked adrenoleukodystrophy
Ciftciler R., GÖKER H., BÜYÜKAŞIK Y., TOPÇU M., Gevher N., DEMİROĞLU H.
TRANSFUSION AND APHERESIS SCIENCE
, cilt.59, sa.1, 2020 (SCI-Expanded, Scopus)
2020
202035. Long-term results of brentuximab vedotin in relapsed and refractory Hodgkin lymphoma: multi-center real-life experience
Ozbalak M., SALİHOĞLU A., Soysal T., Karadogan I., PAYDAŞ S., Ozdemir E., et al.
ANNALS OF HEMATOLOGY
, cilt.99, sa.2, ss.301-307, 2020 (SCI-Expanded, Scopus)
2020
202036. Impact of ABO blood group incompatibility on the outcomes of allogeneic hematopoietic stem cell transplantation
Ciftciler R., GÖKER H., BÜYÜKAŞIK Y., KARAAĞAÇ AKYOL T., AKSU S., Tekin F., et al.
TRANSFUSION AND APHERESIS SCIENCE
, cilt.59, sa.1, 2020 (SCI-Expanded, Scopus)
2020
202037. Evaluation of the Survival Outcomes of Multiple Myeloma Patients According to Their Plasmacytoma Presentation at Diagnosis
Ciftciler R., GÖKER H., DEMİROĞLU H., AKSU S., SAYINALP N., HAZNEDAROĞLU İ. C., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.37, sa.4, ss.256-262, 2020 (SCI-Expanded, Scopus, TRDizin)
2020
202038. The comparison of bone marrow kinetics between patients with acute myeloid leukemia and acute promyelocytic leukemia after induction chemotherapy
Ciftciler R., HAZNEDAROĞLU İ. C., Ozcebe O., AKSU S., SAYINALP N., GÖKER H., et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
, cilt.42, sa.1, ss.17-21, 2020 (SCI-Expanded, Scopus)
2020
202039. Comparison of bortezomib-cyclophosphamide-dexametha-sone versus bortezomib-dexamethasone based regimens in newly diagnosed multiple myeloma patients
Ciftciler R., GÖKER H., BÜYÜKAŞIK Y., SAYINALP N., HAZNEDAROĞLU İ. C., AKSU S., et al.
HEMATOLOGY REPORTS
, cilt.12, sa.1, 2020 (ESCI, Scopus)
2020
202040. The Impact of Early Versus Late Platelet and Neutrophil Recovery after Induction Chemotherapy on Survival Outcomes of Patients with Acute Myeloid Leukemia
Ciftciler R., HAZNEDAROĞLU İ. C., SAYINALP N., Ozcebe O., AKSU S., DEMİROĞLU H., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.37, sa.2, ss.116-120, 2020 (SCI-Expanded, Scopus, TRDizin)
2020
202041. Acute Graft-Versus-Host Disease: A Brief Review
ALADAĞ KARAKULAK E., KELKİTLİ E., GÖKER H.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.37, sa.1, ss.1-4, 2020 (SCI-Expanded, Scopus, TRDizin)
2019
201942. What is the role of the decrease in immunoglobulin level after the first cycle in patient with multiple myeloma?
GÖKER H., KELKİTLİ E., Turgut M.
AMERICAN JOURNAL OF HEMATOLOGY
, cilt.94, 2019 (SCI-Expanded, Scopus)
2019
201943. Impact of Time Between Induction Chemotherapy and Complete Remission on Survival Outcomes in Patients With Acute Myeloid Leukemia
Ciftciler R., DEMİROĞLU H., HAZNEDAROĞLU İ. C., SAYINALP N., AKSU S., Ozcebe O., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
, cilt.19, sa.11, ss.729-734, 2019 (SCI-Expanded, Scopus)
2019
201944. SECONDARY MALIGNANCIES IN PATIENTS WITH MULTIPLE MYELOMA
ALADAĞ KARAKULAK E., BÜYÜKAŞIK Y., DEMİROĞLU H., AKSU S., GÖKER H.
AMERICAN JOURNAL OF HEMATOLOGY
, cilt.94, 2019 (SCI-Expanded, Scopus)
2019
201945. Elotuzumab Plus Pomalidomide or Lenalidomide is Able to Achieve Durable >= Vgpr Responses Among Immunomodulatory/Proteasome Inhibitor Refractory Myeloma Patients: A Report on Multicenter Experience From Turkey
BEKSAÇ M., Seval G. C., PAYDAŞ S., Tuglular T. F., ARSLAN Ö., GÖKER H., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
, cilt.19, sa.10, 2019 (SCI-Expanded, Scopus)
2019
201946. Impact of Pre-transplant and Post-transplant Remission Status of Patients on Survival in Newly Diagnosed Multiple Myeloma
Ciftciler R., GÖKER H., BÜYÜKAŞIK Y., ALADAĞ KARAKULAK E., DEMİROĞLU H.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION
, cilt.35, sa.4, ss.655-661, 2019 (SCI-Expanded, Scopus)
2019
201947. Mantle cell lymphoma: a Turkish Multi-Center Study
OKAY M., MELETLİ Ö., KELKİTLİ E., Malkan Ü. Y., Turgut M., BÜYÜKAŞIK Y., et al.
JOURNAL OF BUON
, cilt.24, sa.5, ss.2084-2089, 2019 (SCI-Expanded, Scopus)
2019
201948. DETERMINANTS OF CARDIORESPIRATORY FITNESS LEVEL IN HEMATOPOIETIC STEM CELL TRANSPLANTATION CANDIDATES
YILDIZ KABAK V., GÖKER H., ATASAVUN UYSAL S., DEMİROĞLU H., ALADAĞ KARAKULAK E., OKAY M., et al.
TURKISH JOURNAL OF PHYSIOTHERAPY REHABILITATION-TURK FIZYOTERAPI VE REHABILITASYON DERGISI
, cilt.30, sa.2, ss.81-88, 2019 (ESCI, Scopus, TRDizin)
2019
201949. Impact of bone marrow plasma cells percentage on survival at diagnosis and pre-transplant period in newly diagnosed multiple myeloma: Experience of a single center from Turkey
Ciftciler R., GÖKER H., BÜYÜKAŞIK Y., ALADAĞ KARAKULAK E., Saglam E. A., DEMİROĞLU H.
TRANSFUSION AND APHERESIS SCIENCE
, cilt.58, sa.3, ss.313-317, 2019 (SCI-Expanded, Scopus)
2019
201950. Extramedullary relapses of acute leukemias after allogeneic hematopoietic stem cell transplantation: clinical features, cumulative incidence, and risk factors
Gunes G., GÖKER H., DEMİROĞLU H., Malkan Ü. Y., BÜYÜKAŞIK Y.
BONE MARROW TRANSPLANTATION
, cilt.54, sa.4, ss.595-600, 2019 (SCI-Expanded, Scopus)
2019
201951. Efficacy and Feasibility of Allogeneic Hematopoietic Stem-Cell Transplantation in the Treatment of Refractory Acute Myeloid Leukemia
Ciftciler R., DEMİROĞLU H., BÜYÜKAŞIK Y., ALADAĞ KARAKULAK E., AKSU S., HAZNEDAROĞLU İ. C., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
, cilt.19, sa.3, ss.177-182, 2019 (SCI-Expanded, Scopus)
2019
201952. Unclassifiable non-CML classical myeloproliferative diseases with microcytosis: findings indicating diagnosis of polycythemia vera masked by iron deficiency
ALADAĞ KARAKULAK E., AKSU S., DEMİROĞLU H., SAYINALP N., GÖKER H., HAZNEDAROĞLU İ. C., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.49, sa.5, ss.1560-1563, 2019 (SCI-Expanded, Scopus, TRDizin)
2019
201953. Comparison of Myeloablative Versus Reduced-Intensity Conditioning Regimens for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia: A Cohort Study
Ciftciler R., GÖKER H., DEMİROĞLU H., ALADAĞ KARAKULAK E., AKSU S., HAZNEDAROĞLU İ. C., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.36, sa.2, ss.88-96, 2019 (SCI-Expanded, Scopus, TRDizin)
2019
201954. Mitoxantrone-melphalan conditioning regimen for autologous stem cell transplantation in relapsed/refractory lymphoma
OKAY M., BÜYÜKAŞIK Y., DEMİROĞLU H., Malkan Ü. Y., Ciftciler R., ALADAĞ KARAKULAK E., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.49, sa.4, ss.985-992, 2019 (SCI-Expanded, Scopus, TRDizin)
2019
201955. Impact of pre-transplant bone marrow blast percentage on survival in acute myeloid leukemia patients
Ciftciler R., GÖKER H., BÜYÜKAŞIK Y., Malkan Ü. Y., Saglam E. A., DEMİROĞLU H.
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE
, cilt.12, sa.7, ss.9288-9294, 2019 (SCI-Expanded)
2018
201856. Effect of postremission high dose cytarabine-based consolidation chemotherapy before allogenic stem cell transplantation in outcomes of acute myeloid leukemia patients
CIFTCILER R., DEMİROĞLU H., BÜYÜKAŞIK Y., OKAY M., AKSU S., Sayinalp N., et al.
TRANSFUSION AND APHERESIS SCIENCE
, cilt.57, sa.6, ss.752-755, 2018 (SCI-Expanded, Scopus)
2018
201857. Evaluation of Secondary Malignancies in Chronic Lymphocytic Leukemia
DEMİROĞLU H., SAYINALP N., GÖKER H., BÜYÜKAŞIK Y., ÖZCEBE O. İ., HAZNEDAROĞLU İ. C., et al.
Journal of Global Oncology , ss.205, 2018 (ESCI)
2018
201858. Hematopoietic stem cell transplantation in geriatric patients in Turkey
GÖKER H., KELKİTLİ E., BÜYÜKAŞIK Y., DEMİROĞLU H.
TRANSFUSION AND APHERESIS SCIENCE
, cilt.57, sa.2, ss.159-162, 2018 (SCI-Expanded, Scopus)
2018
201859. Immunosuppression-associated posterior reversible encephalopathy syndrome in an acute leukemia case
Malkan U. Y., GÜNEŞ G., DEMİROĞLU H., GÖKER H.
HEMATOLOGY REPORTS
, cilt.10, sa.4, ss.96-97, 2018 (ESCI, Scopus)
2018
201860. Pediatric Chemotherapeutic Regimen (BFM-95) is Superior for Overall Survival in Adult Acute Lymphoblastic Leukemia
KARCIOĞLU A. M., OKAY M., BÜYÜKAŞIK Y., Malkan Ü. Y., SAYINALP N., DEMİROĞLU H., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.28, sa.4, ss.254-260, 2018 (SCI-Expanded, Scopus, TRDizin)
2017
201761. Autologous hematopoietic progenitor cell mobilization and collection in adult patients presenting with multiple myeloma and lymphoma: A position-statement from the Turkish Society of Apheresis (TSA)
Tekgunduz E., Arat M., GÖKER H., Ozdogu H., KAYNAR L., Cagirgan S., et al.
TRANSFUSION AND APHERESIS SCIENCE
, cilt.56, sa.6, ss.845-849, 2017 (SCI-Expanded, Scopus)
2017
201762. Biosimilar filgrastim (leucostim (R)) have similar efficacy in steady-state hematopoietic progenitor cell mobilization compared to original filgrastim (neupogen (R)) and lenograstim (granocyte (R)): A retrospective multicenter study
Kayikci O., Tekgunduz E., Kaya A. H., GÖKER H., Aslan A., Iskender D., et al.
TRANSFUSION AND APHERESIS SCIENCE
, cilt.56, sa.6, ss.832-835, 2017 (SCI-Expanded, Scopus)
2017
201763. Current practice of autologous hematopoietic progenitor cell mobilization in adult patients with multiple myeloma and lymphoma: The results of a survey from Turkish hematology research and education group (ThREG)
Tekgunduz E., DEMİRKAN F., VURAL F., GÖKER H., Ozdogu H., KİKİ İ., et al.
TRANSFUSION AND APHERESIS SCIENCE
, cilt.56, sa.6, ss.804-808, 2017 (SCI-Expanded, Scopus)
2017
201764. Sole Infrequent Karyotypic Aberration Trisomy 6 in a Patient with Acute Myeloid Leukemia and Breast Cancer in Remission
AYDIN M. S., BOZKURT S., GÜNEŞ G., Malkan Ü. Y., Aslan T., ETGÜL S., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.34, sa.1, ss.103-104, 2017 (SCI-Expanded, Scopus, TRDizin)
2016
201665. Reversible diffusion restriction of optic radiations: A distinct form of cyclosporine induced leukoencephalopathy presenting with visual loss
GÖÇMEN R., Colpak A. I., GÖKER H., Kaya A. A., Onder H.
JOURNAL OF THE NEUROLOGICAL SCIENCES
, cilt.366, ss.155-157, 2016 (SCI-Expanded, Scopus)
2016
201666. Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in Daily Practice: A Multicenter Experience
Tekgunduz E., GÖKER H., KAYNAR L., SARI İ., Pala C., Dogu M. H., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
, cilt.16, sa.5, ss.269-274, 2016 (SCI-Expanded, Scopus)
2016
201667. Association of Macroeconomic Factors With Nonrelapse Mortality After Allogeneic Hematopoietic Cell Transplantation for Adults With Acute Lymphoblastic Leukemia: An Analysis From the Acute Leukemia Working Party of the EBMT
Giebel S., Labopin M., Ibatici A., Browne P., Czerw T., Socie G., et al.
ONCOLOGIST
, cilt.21, sa.3, ss.377-383, 2016 (SCI-Expanded, Scopus)
2016
201668. Hematopoietic cell transplantation activity of Turkey in 2014: Ongoing increase in HCT rates
Tekgunduz E., Sencan I., Kapuagasi A., Unal D., Oztturk M., Gumus E., et al.
TRANSFUSION AND APHERESIS SCIENCE
, cilt.54, sa.1, ss.53-59, 2016 (SCI-Expanded, Scopus)
2016
201669. Chimeric antigen receptor T cell treatment in hematologic malignancies
GÖKER H., Malkan Ü. Y., DEMİROĞLU H., BÜYÜKAŞIK Y.
TRANSFUSION AND APHERESIS SCIENCE
, cilt.54, sa.1, ss.35-40, 2016 (SCI-Expanded, Scopus)
2016
201670. Retrospective analysis of adult patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic cell transplantation: A multicenter experience of daily practice
Tekgunduz E., KAYNAR L., GÖKER H., Kaya A. H., ERMİŞ TURAK E., ELİAÇIK E., et al.
TRANSFUSION AND APHERESIS SCIENCE
, cilt.54, sa.1, ss.41-47, 2016 (SCI-Expanded, Scopus)
2016
201671. The Impact of Iron Overload on Transplant-Related Complications and Prognosis of Acute Leukemias
Malkan U. Y., GÜNEŞ G., ELİAÇIK E., HAZNEDAROĞLU İ. C., Yayar O., ETGÜL S., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.26, sa.1, ss.54-60, 2016 (SCI-Expanded, Scopus, TRDizin)
2016
201672. Comparison of Myelodysplastic Syndrome Prognostic Scoring Systems
BEKTAŞ Ö., ÜNER A., ELİAÇIK E., Uz B., Isik A., ETGÜL S., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.33, sa.2, ss.119-126, 2016 (SCI-Expanded, Scopus, TRDizin)
2016
201673. Idelalisib at the Crossroads of B-Cell Lymphoproliferative Disorders
AKSU S., Ayyildiz O., ETGÜL S., GÖKER H., GÜNEŞ G., HAZNEDAROĞLU İ. C., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.26, sa.1, ss.12-19, 2016 (SCI-Expanded, Scopus, TRDizin)
2016
201674. The Impact of Jak1/Jak2 Inhibitor Ruxolitinib on the Spleen Size and Symptom Burden in Myeloproliferative Diseases
Aktimur S. H., Malkan U. Y., Eyupoglu D. N., HAZNEDAROĞLU İ. C., KELKİTLİ E., Atay H. M., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.26, sa.3, ss.153-158, 2016 (SCI-Expanded, Scopus, TRDizin)
2016
201675. The Prognosis of Adult Burkitt's Cell Leukemia in Real-Life Clinical Practice
Malkan Ü. Y., GÜNEŞ G., GÖKER H., HAZNEDAROĞLU İ. C., Acar K., ELİAÇIK E., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.33, sa.4, ss.281-285, 2016 (SCI-Expanded, Scopus, TRDizin)
2015
201576. High frequency of autonomous T-cell proliferation compatible with T-cell large granular lymphocytic leukemia in patients with cytopenia of unknown etiology
BEKTAŞ Ö., ÜNER A., Aydin S. M., ELİAÇIK E., Uz B., Isik A., et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY
, cilt.102, sa.2, ss.211-217, 2015 (SCI-Expanded, Scopus)
2015
201577. Optimizing mobilization strategies in difficult-to-mobilize patients: The role of plerixafor
GÖKER H., ETGÜL S., BÜYÜKAŞIK Y.
TRANSFUSION AND APHERESIS SCIENCE
, cilt.53, sa.1, ss.23-29, 2015 (SCI-Expanded, Scopus)
2015
201578. Bone marrow fibrosis may be an effective independent predictor of the 'TKI drug response level' in chronic myeloid leukemia
ELİAÇIK E., Isik A., Aydin C., ÜNER A., AKSU S., SAYINALP N., et al.
HEMATOLOGY
, cilt.20, sa.7, ss.392-396, 2015 (SCI-Expanded, Scopus)
2015
201579. Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey
Salihoglu A., Elverdi T., KARADOGAN I., PAYDAŞ S., ÖZDEMİR E., ERDEM G., et al.
ANNALS OF HEMATOLOGY
, cilt.94, sa.3, ss.415-420, 2015 (SCI-Expanded, Scopus)
2015
201580. Rebound Thrombocytosis following Induction Chemotherapy Is an Independent Predictor of a Good Prognosis in Acute Myeloid Leukemia Patients Attaining First Complete Remission
Malkan Ü. Y., Gunes G., Isik A., Eliacik E., Etgul S., Aslan T., et al.
ACTA HAEMATOLOGICA
, cilt.134, sa.1, ss.32-37, 2015 (SCI-Expanded, Scopus)
2015
201581. Clinicopathological associations of acquired erythroblastopenia
GÜNEŞ G., Malkan Ü. Y., YAŞAR H. A., ELİAÇIK E., HAZNEDAROĞLU İ. C., DEMİROĞLU H., et al.
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE
, cilt.8, sa.12, ss.22515-22519, 2015 (SCI-Expanded, Scopus)
2015
201582. Generic Imatinib Mesylate is as Effective as Original Glivec in the Clinical Management of CML
Malkan U. Y., AKSU S., Aktimur S. H., Atay H., Bektas O., BÜYÜKAŞIK Y., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.25, sa.4, ss.215-221, 2015 (SCI-Expanded, Scopus, TRDizin)
2015
201583. Late Onset and Protracted Course of Steroid Refractory Chronic Graft-versus-Host Disease
GÜNEŞ G., DEMİROĞLU H., GÖKER H., Malkan Ü. Y., ELİAÇIK E., Yayar O., et al.
CASE REPORTS IN HEMATOLOGY
, 2015 (ESCI)
2015
201584. Pharmacobiological Approach for the Clinical Development of Ruxolitinib in Myeloproliferative Neoplasms
ELİAÇIK E., Isik A., AKSU S., ÜNER A., BÜYÜKAŞIK Y., SAYINALP N., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.32, sa.2, ss.163-167, 2015 (SCI-Expanded, Scopus, TRDizin)
2015
201585. The factors affecting early death after the initial therapy of acute myeloid leukemia
Malkan Ü. Y., GÜNEŞ G., ELİAÇIK E., HAZNEDAROĞLU İ. C., ETGÜL S., Aslan T., et al.
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE
, cilt.8, sa.12, ss.22564-22569, 2015 (SCI-Expanded, Scopus)
2014
201486. Rebound Thrombocytosis Is an Independent Predictor of Good Prognosis in AML Patients Attaining First Complete Remission
Malkan Ü. Y., GÜNEŞ G., GÖKER H., ELİAÇIK E., Isik A., SAYINALP N., et al.
BLOOD
, cilt.124, sa.21, 2014 (SCI-Expanded, Scopus)
2014
201487. Massive Life-Threatening Hemorrhages Due to Toxic Oral Intake of 3750 Mg Dabigatran Etexilate As a Suicide Attempt and the Clinical Management
GÜNEŞ G., Malkan Ü. Y., AKSU S., HAZNEDAROĞLU İ. C., BÜYÜKAŞIK Y., SAYINALP N., et al.
BLOOD
, cilt.124, sa.21, 2014 (SCI-Expanded, Scopus)
2014
201488. Local Renin-Angiotensin System in Normal Hematopoietic and Multiple Myeloma-Related Progenitor Cells
Uz B., Tatonyan S. C., Sayitoglu M., Erbilgin Y., Hatirnaz O., AKSU S., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.31, sa.2, ss.136-142, 2014 (SCI-Expanded, Scopus, TRDizin)
2014
201489. Impact of Postremission Consolidation Chemotherapy on Outcome After Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation for Patients With Acute Myeloid Leukemia in First Complete Remission
Yeshurun M., Labopin M., Blaise D., Cornelissen J. J., Sengeloev H., Vindelov L., et al.
CANCER
, cilt.120, sa.6, ss.855-863, 2014 (SCI-Expanded, Scopus)
2014
201490. An Immune Thrombocytopenic Purpura-Like Picture Preceding Chronic Myelomonocytic Leukemia: A Case Series and Review of the Literature
Albayrak M., ELİAÇIK E., KORUCU B., Isik A., GÜNEŞ G., AKSU S., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.24, sa.3, ss.213-216, 2014 (SCI-Expanded, Scopus, TRDizin)
2014
201491. Vitamin B-12 Deficiency with the Absence of Anemia in Young and Middle-Aged Population
Kara A., Eliacik E., BÜYÜKAŞIK Y., ÖZCEBE O. İ., Haznedaroglu I., AKSU S., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.24, sa.3, ss.190-194, 2014 (SCI-Expanded, Scopus, TRDizin)
2014
201492. Ibrutinib: From Molecule to Medicine
Ayyildiz O., Demirkan F., GÖKER H., HAZNEDAROĞLU İ. C., Ilhan O., KAYNAR L., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.24, sa.3, ss.4-14, 2014 (SCI-Expanded, Scopus, TRDizin)
2014
201493. Acute in Vitro effects of ABS (Ankaferd Hemostat) on the Lymphoid Neoplastic Cells (B-CLL and RAJI Tumor Cell Lines)
AKALIN İ., Okur F. V., HAZNEDAROĞLU İ. C., SAYINALP N., AKSU S., BÜYÜKAŞIK Y., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.24, sa.4, ss.253-259, 2014 (SCI-Expanded, Scopus, TRDizin)
2013
201394. Local hematopoietic renin-angiotensin system in myeloid versus lymphoid hematological neoplastic disorders
Uz B., Tatonyan S. C., Sayitoglu M., Erbilgin Y., Ng O. H., BÜYÜKAŞIK Y., et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
, cilt.14, sa.4, ss.308-314, 2013 (SCI-Expanded, Scopus)
2013
201395. Co-expression of t(5;17) and t(8;21) in a Case of Acute Promyelocytic Leukemia: Review of the Literature
Uz B., ELİAÇIK E., Isik A., AKSU S., BÜYÜKAŞIK Y., HAZNEDAROĞLU İ. C., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.30, sa.4, ss.400-404, 2013 (SCI-Expanded, Scopus, TRDizin)
2013
201396. Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic hematopoietic stem cell transplantation for acute leukemia patients: A single center experience
GÖKER H., Ozdemir E., UZ B., BÜYÜKAŞIK Y., Turgut M., SEREFHANOGLU S., et al.
TRANSFUSION AND APHERESIS SCIENCE
, cilt.49, sa.3, ss.590-599, 2013 (SCI-Expanded, Scopus)
2013
201397. EUTOS CML prognostic scoring system predicts ELN-based 'event-free survival' better than Euro/Hasford and Sokal systems in CML patients receiving front-line imatinib mesylate
Uz B., BÜYÜKAŞIK Y., Atay H., KELKİTLİ E., Turgut M., BEKTAŞ Ö., et al.
HEMATOLOGY
, cilt.18, sa.5, ss.247-252, 2013 (SCI-Expanded, Scopus)
2013
201398. The Impact of Eltrombopag Administration on the Clinical Course of Severe Refractory Fatal Acquired Aplastic Anemia
Isik A., ELİAÇIK E., HAZNEDAROĞLU İ. C., AKSU S., SAYINALP N., BÜYÜKAŞIK Y., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.30, sa.3, ss.328-330, 2013 (SCI-Expanded, Scopus, TRDizin)
2013
201399. ULTRASTRUCTURAL ANALYSES OF THE NOVEL CHIMERIC HEMOSTATIC AGENT GENERATED VIA NANOTECHNOLOGY, ABS NANOHEMOSTAT, AT THE RENAL TISSUE LEVEL
Huri E., HAZNEDAROĞLU İ. C., Hayran M., Ergun M., FIRAT A., Beyazit Y., et al.
HAEMATOLOGICA
, cilt.98, ss.439, 2013 (SCI-Expanded, Scopus)
2013
2013100. Long-Term Sustained Hemorrhage Due to Bone Marrow Biopsy Successfully Treated With Topical Ankaferd Hemostat in a Bleeding-Prone Patient With Secondary Amyloidosis
Uz B., SAİN GÜVEN G., Isik A., KUYUMCU M. E., BEKTAŞ Ö., ELİAÇIK E., et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
, cilt.19, sa.3, ss.338-340, 2013 (SCI-Expanded, Scopus)
2013
2013101. Prognostic importance of additional cytogenetic anomalies in chronic myeloid leukemia
BOZKURT S., Uz B., BÜYÜKAŞIK Y., BEKTAŞ Ö., Inanc A., GÖKER H., et al.
MEDICAL ONCOLOGY
, cilt.30, sa.1, 2013 (SCI-Expanded, Scopus)
2013
2013102. Bone Marrow Iron Staining is a Reliable Test for Elimination of Iron Deficiency Anemia Rather than its Diagnosis
Koca E., Cetiner D. A., BÜYÜKAŞIK Y., ÜNER A., SAYINALP N., HAZNEDAROĞLU İ. C., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.23, sa.4, ss.260-263, 2013 (SCI-Expanded, Scopus, TRDizin)
2013
2013103. Renin-Angiotensin System (RAS) Expressions in Myeloid Leukemic Cell Lines
Uz B., Tatonyan S. C., Sayitoglu M., Erbilgin Y., Hatirnaz Ng O., BÜYÜKAŞIK Y., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.23, sa.4, ss.264-268, 2013 (SCI-Expanded, Scopus, TRDizin)
2013
2013104. Hyper-CVAD Regimen in Routine Management of Adult Acute Lymphoblastic Leukemia: A Retrospective Multicenter Study
BÜYÜKAŞIK Y., Acar K., Kelkitli E., UZ B., SEREFHANOGLU S., Ozdemir E., et al.
ACTA HAEMATOLOGICA
, cilt.130, sa.3, ss.199-205, 2013 (SCI-Expanded, Scopus)
2012
2012105. Mobilized peripheral blood stem cells compared with bone marrow from HLA-identical siblings for reduced-intensity conditioning transplantation in acute myeloid leukemia in complete remission: a retrospective analysis from the Acute Leukemia Working Party of EBMT
Nagler A., Labopin M., Shimoni A., Mufti G. J., Cornelissen J. J., Blaise D., et al.
EUROPEAN JOURNAL OF HAEMATOLOGY
, cilt.89, sa.3, ss.206-213, 2012 (SCI-Expanded, Scopus)
2012
2012106. Effective Molecular Monitoring and the Proper Management of Pleural Effusion During the First-Line Dasatinib Administration in CML
AKSU S., BEKTAŞ Ö., Uz B., BÜYÜKAŞIK Y., SAYINALP N., Ozcebe O., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.22, sa.1, ss.1-7, 2012 (SCI-Expanded, Scopus, TRDizin)
2012
2012107. Unusual Extramedullary Recurrence and Renal Relapse Despite Complete Chimerysm after Allografting in Ph+ ALL
Serefhanoglu S., GÖKER H., BAYDAR D., ÜNER A., ARICI M., HAZNEDAROĞLU İ. C., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.22, sa.1, ss.46-50, 2012 (SCI-Expanded, Scopus, TRDizin)
2012
2012108. A Placebo-Controlled, Randomized, Double-Blinded, Cross-Over Phase-I Clinical Study Indicating the Safety of Topical Ankaferd Hemostat in Healthy Volunteers
Balcik O. S., Koroglu M., Cipil H., Kaftan O., Maral S., Gurel A., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.22, sa.4, ss.267-274, 2012 (SCI-Expanded, Scopus, TRDizin)
2011
2011109. Eculizumab before and after allogeneic hematopoietic stem cell transplantation in a patient with paroxysmal nocturnal hemoglobinuria
GÖKER H., Uz B., BÜYÜKAŞIK Y., AKSU S., Haznedaroglu I., SAYINALP N., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.28, sa.3, ss.223-227, 2011 (SCI-Expanded, Scopus, TRDizin)
2011
2011110. Surgical and histopathological effects of topical Ankaferd (R) hemostat on major arterial vessel injury related to elevated intra-arterial blood pressure
Ulus A. T., TURAN DURAL N. N., Ozyalcin S., Aydog G., Ulus F., GÖKER H., et al.
TURKISH JOURNAL OF HEMATOLOGY
, cilt.28, sa.3, ss.206-212, 2011 (SCI-Expanded, Scopus, TRDizin)
2011
2011111. Naturally acquired hepatitis A antibodies after haematopoetic stem cell transplantation
YALÇIN S. S., Kondolot M., GÖKER H., KUŞKONMAZ B. B., Karacan Y., ÇETİN M., et al.
EPIDEMIOLOGY AND INFECTION
, cilt.139, sa.5, ss.683-687, 2011 (SCI-Expanded, Scopus)
2011
2011112. A Comparison of Jurkat Cell-Reactive Anti-T Lymphocyte Globulin and Fetal Anti-Thymocyte Globulin Preparations in the Treatment of Aplastic Anemia
Serefhanoglu S., Buyukasik Y., Purnak T., Goker H., Sayinalp N., Haznedaroglu I. C., et al.
MEDICAL PRINCIPLES AND PRACTICE
, cilt.20, sa.4, ss.341-344, 2011 (SCI-Expanded, Scopus)
2011
2011113. Identification of clinical and simple laboratory variables predicting responsible gastrointestinal lesions in patients with iron deficiency anemia
Serefhanoglu S., BÜYÜKAŞIK Y., Emmungil H., SAYINALP N., HAZNEDAROĞLU İ. C., GÖKER H., et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES
, cilt.8, sa.1, ss.30-38, 2011 (SCI-Expanded, Scopus)
2011
2011114. THE FACTORS INFLUENCING OVERALL SURVIVAL IN NEWLY DIAGNOSED ADULT ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS
Serefhanoglu S., BÜYÜKAŞIK Y., AKSU S., GÖKER H., SAYINALP N., Cetgner D., et al.
JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI
, cilt.74, sa.1, ss.7-12, 2011 (ESCI, TRDizin)
2011
2011115. Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group
BEKSAÇ M., HAZNEDAR R., Firatli-Tuglular T., Ozdogu H., Aydogdu I., Konuk N., et al.
EUROPEAN JOURNAL OF HAEMATOLOGY
, cilt.86, sa.1, ss.16-22, 2011 (SCI-Expanded, Scopus)
2011
2011116. Topical Ankaferd Bloodstopper in the Management of Critical Bleedings due to Hemorrhagic Diathesis
Turgut M., Tutkun F., Celebi N., MUĞLALI M., HAZNEDAROĞLU İ. C., GÖKER H.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.21, sa.3, ss.160-165, 2011 (SCI-Expanded, Scopus, TRDizin)
2010
2010117. Clinical features and outcomes of 49 Turkish patients with acute promyelocytic leukemia who received ATRA and anthracyclines (PETHEMA protocol) therapy
SEREFHANOGLU S., BÜYÜKAŞIK Y., GÖKER H., SAYINALP N., HAZNEDAROĞLU İ. C., AKSU S., et al.
LEUKEMIA RESEARCH
, cilt.34, sa.12, 2010 (SCI-Expanded, Scopus)
2010
2010118. Determination of burnout levels of nurses working in stem cell transplantation units in Turkey
AKKUŞ Y., Karacan Y., GÖKER H., AKSU S.
NURSING & HEALTH SCIENCES
, cilt.12, sa.4, ss.444-449, 2010 (SCI-Expanded, SSCI, Scopus)
2010
2010119. Evaluation of Hemostatic Effects of Ankaferd as an Alternative Medicine
Beyazit Y., Kurt M., Kekilli M., GÖKER H., HAZNEDAROĞLU İ. C.
ALTERNATIVE MEDICINE REVIEW
, cilt.15, sa.4, ss.329-336, 2010 (SCI-Expanded, Scopus)
2010
2010120. Oral Systemic Administration of Ankaferd Blood Stopper Has No Short-Term Toxicity in an In Vivo Rabbit Experimental Model
Bilgili H., Captug O., Kosar A., Kurt M., Kekilli M., Shorbagi A., et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
, cilt.16, sa.5, ss.533-536, 2010 (SCI-Expanded, Scopus)
2010
2010121. Serological response to influenza vaccine after hematopoetic stem cell transplantation
YALÇIN Ş., Kondolot M., Albayrak N., Altas A. B., Karacan Y., Kuskonmaz B. B., et al.
ANNALS OF HEMATOLOGY
, cilt.89, sa.9, ss.913-918, 2010 (SCI-Expanded, Scopus)
2010
2010122. Ultrastructural and Morphological Analyses of the In Vitro and In Vivo Hemostatic Effects of Ankaferd Blood Stopper
Haznedaroglu B. Z., Haznedaroğlu İ. C., Walker S. L., Bilgili H., Göker H., Kosar A., et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
, cilt.16, sa.4, ss.446-453, 2010 (SCI-Expanded, Scopus)
2010
2010123. Prognostic Factors Affecting the Clinical Course of non-Hodgkin's Lymphomas
Beyazit Y., Kekilli M., Purnak T., GÖKER H., AKSU S., HAZNEDAROĞLU İ. C., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.20, sa.2, ss.96-102, 2010 (SCI-Expanded, Scopus, TRDizin)
2010
2010124. Antimicrobial activity of Ankaferd Blood StopperA (R) against nosocomial bacterial pathogens
SARIBAŞ Z., ŞENER B., HAZNEDAROĞLU İ. C., Hascelik G., Kirazli S., GÖKER H.
CENTRAL EUROPEAN JOURNAL OF MEDICINE
, cilt.5, sa.2, ss.198-202, 2010 (SCI-Expanded, Scopus)
2010
2010125. Safety and Efficacy of Ankaferd Blood Stopper in Dental Surgery
Ercetın S., Haznedaroğlu İ. C., Kurt M., Onal I. K., Aktaş A., Kurt O. K., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.20, sa.1, ss.1-5, 2010 (SCI-Expanded, Scopus, TRDizin)
2010
2010126. The Gray-Zone Concept, Suboptimal Response to Imatinib, Shall be Removed from the ELN-CML Recommendations
HAZNEDAROĞLU İ. C., Koca E., AKSU S., GÖKER H., SAYINALP N., BÜYÜKAŞIK Y., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.20, sa.2, ss.25-26, 2010 (SCI-Expanded, Scopus, TRDizin)
2010
2010127. Dasatinib-Induced Tumor Lysis Syndrome and Following Hematologic Remission in Fibrotic Blastic Crisis of CML
BEKTAŞ Ö., HAZNEDAROĞLU İ. C., BÜYÜKAŞIK Y., SAYINALP N., AKSU S., GÖKER H., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, cilt.20, sa.2, ss.13-16, 2010 (SCI-Expanded, Scopus, TRDizin)
2010
2010128. Spinal Myeloid Sarcoma in Two Non-Leukemic Patients
Serefhanoglu S., GÖKER H., AKSU S., BÜYÜKAŞIK Y., SAYINALP N., HAZNEDAROĞLU İ. C., et al.
INTERNAL MEDICINE
, cilt.49, sa.22, ss.2493-2497, 2010 (SCI-Expanded, Scopus)
2010
2010129. Concomitant renal cell carcinoma and lymphoid malignancies: a case series of five patients and review of the literature
Serefhanoglu S., BÜYÜKAŞIK Y., GÖKER H., Akin S. C., Akin S., SAYINALP N., et al.
MEDICAL ONCOLOGY
, cilt.27, sa.1, ss.55-58, 2010 (SCI-Expanded, Scopus)
2010
2010130. DISEASE CHARACTERISTICS AND FACTORS INFLUENCING TREATMENT RESPONSE IN NEWLY DIAGNOSED ACUTE MYELOBLASTIC LEUKEMIA PATIENTS: A SINGLE CENTER EXPERIENCE
Serefhanoglu S., BÜYÜKAŞIK Y., AKSU S., GÖKER H., SAYINALP N., Cetiner D., et al.
JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI
, cilt.73, sa.3, ss.74-79, 2010 (ESCI, TRDizin)
2009
2009131. Changes in vascular endothelial growth factor, angiopoietins, and Tie-2 levels with G-CSF stimulation in healthy donors
Serefhanoglu S., GÖKER H., BÜYÜKAŞIK Y., Turgut M., SAYINALP N., HAZNEDAROĞLU İ. C., et al.
ANNALS OF HEMATOLOGY
, cilt.88, sa.7, ss.667-671, 2009 (SCI-Expanded, Scopus)
2009
2009132. In Vivo Hemostatic Effect of the Medicinal Plant Extract Ankaferd Blood Stopper in Rats Pretreated With Warfarin
Cipil H. S., Kosar A., Kaya A., Uz B., HAZNEDAROĞLU İ. C., GÖKER H., et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
, cilt.15, sa.3, ss.270-276, 2009 (SCI-Expanded, Scopus)
2009
2009133. The efficacy of Ankaferd Blood Stopper in antithrombotic drug-induced primary and secondary hemostatic abnormalities of a rat-bleeding model
Kosar A., Cipil H. S., Kaya A., Uz B., HAZNEDAROĞLU İ. C., GÖKER H., et al.
BLOOD COAGULATION & FIBRINOLYSIS
, cilt.20, sa.3, ss.185-190, 2009 (SCI-Expanded, Scopus)
2009
2009134. Transformation of Adult Myelodysplastic Syndrome-Refractory Anemia to Acute T-Cell Lymphoblastic Leukemia
Serefhanoglu S., GÖKER H., BÜYÜKAŞIK Y., SAYINALP N., ÖZCEBE O. İ.
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION
, cilt.101, sa.4, ss.370-372, 2009 (SCI-Expanded, Scopus)
2009
2009135. In Vitro Anti-Bacterial Activities of Ankaferd Medicinal Plant Extract
Akkoc N., AKÇELİK M., HAZNEDAROĞLU İ. C., GÖKER H., Turgut M., AKSU S., et al.
TURKIYE KLINIKLERI TIP BILIMLERI DERGISI
, cilt.29, sa.2, ss.410-415, 2009 (SCI-Expanded, Scopus)
2009
2009136. The Effect of the Chernobyl Disaster on the Occurrence of Adult Acute Leukemias in Turkey
Ozatli D., GÖKER H., Buyuhasik Y., Sayinalp N., HAZNEDAROĞLU İ. C., ÖZCEBE O. İ.
TURKIYE KLINIKLERI TIP BILIMLERI DERGISI
, cilt.29, sa.2, ss.388-394, 2009 (SCI-Expanded, Scopus)
2009
2009137. Biphenotypic Acute Leukemia Treated With Acute Myeloid Leukemia Regimens: A Case Series
Serefhanoglu S., BÜYÜKAŞIK Y., GÖKER H., SAYINALP N., ÖZCEBE O. İ.
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION
, cilt.101, sa.3, ss.270-272, 2009 (SCI-Expanded, Scopus)
2009
2009138. Multiple Bulky Cutaneous Plasmacytomas with CNS Relapse without Bone Marrow Involvement during the Course of a Lambda Light Chain Myeloma
Serefhanoglu S., HAZNEDAROĞLU İ. C., GÖKER H., BÜYÜKAŞIK Y., ÖZCEBE O. İ.
ONKOLOGIE
, cilt.32, sa.11, ss.662-664, 2009 (SCI-Expanded, Scopus)
2009
2009139. Hemostatic Efficacy of Ankaferd Blood Stopper (R) in a Swine Bleeding Model
Bilgili H., Kosar A., Kurt M., Onal I. K., GÖKER H., Captug O., et al.
MEDICAL PRINCIPLES AND PRACTICE
, cilt.18, sa.3, ss.165-169, 2009 (SCI-Expanded, Scopus)
2008
2008140. Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper Response
HAZNEDAROĞLU İ. C., GÖKER H.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
, cilt.36, sa.6, ss.1448-1449, 2008 (SCI-Expanded, Scopus)
2008
2008141. Effect of platelet count on secretion capacity: formulization and use of the formulae for evaluation of platelet secretion in thrombocytopenic patients
BÜYÜKAŞIK Y., GÖKER H., Buyukasik N. S., SAYINALP N., HAZNEDAROĞLU İ. C., Ozcebea O. I.
BLOOD COAGULATION & FIBRINOLYSIS
, cilt.19, sa.7, ss.633-637, 2008 (SCI-Expanded, Scopus)
2008
2008142. Extramedullary plasmacytomas of the thyroid and pericardium as initial presentation of multiple myeloma
Serefhanoglu S., SAYINALP N., HAZNEDAROĞLU İ. C., GÖKER H., Cetiner D., AKSU S., et al.
ANNALS OF HEMATOLOGY
, cilt.87, sa.10, ss.853-854, 2008 (SCI-Expanded, Scopus)
2008
2008143. Evidence for higher red blood cell mass in persons with unconjugated Hyperbilirubinemia and Gilbert's syndrome
BÜYÜKAŞIK Y., Akman U., Buyukasik N. S., GÖKER H., Kilicarslan A., Shorbagi A. I., et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES
, cilt.335, sa.2, ss.115-119, 2008 (SCI-Expanded, Scopus)
2008
2008144. Soluble platelet glycoprotein V in distinct disease states of pathological thrombopoiesis
Acar K., AKSU S., Beyazit Y., HAZNEDAROĞLU İ. C., Koca E., Cetiner D., et al.
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION
, cilt.100, sa.1, ss.86-90, 2008 (SCI-Expanded, Scopus)
2007
2007145. Angiotensin-converting enzyme expression of the lymphoma-associated macrophages in the lymph nodes of Hodgkin's disease
Koca E., Haznedaroglu I. C., ÜNER A., Sayinalp N., Saglam A. E., Goker H., et al.
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION
, cilt.99, sa.11, ss.1243-1246, 2007 (SCI-Expanded, Scopus)
2007
2007146. Chemotherapy and imatinib-induced molecular remission in lymphoid blast crisis after 20 years of "untreated" chronic myeloid leukemia
Koca E., Sevimli F., Cetiner D., Haznedaroglu I. C., Sayinalp N., Buyukasik Y., et al.
AMERICAN JOURNAL OF HEMATOLOGY
, cilt.82, sa.4, ss.333, 2007 (SCI-Expanded, Scopus)
2006
2006147. Plasma osteopontin levels are elevated in non-ST-segment elevation acute coronary syndromes
Coskun S., Atalar E., Ozturk E., Yavuz B., Ozer N., Goker H., et al.
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION
, cilt.98, sa.11, ss.1746-1750, 2006 (SCI-Expanded, Scopus)
2006
2006148. Spontaneous splenic rupture in a healthy allogeneic donor of peripheral-blood stem cell following the administration of granulocyte colony-stimulating factor (g-csf). A case report and review of the literature
Nuamah N. M., GÖKER H., Kilic Y. A., Dagmoura H., ÇAKMAK A.
HAEMATOLOGICA
, cilt.91, ss.26-28, 2006 (SCI-Expanded, Scopus)
2006
2006149. Couda equina syndrome as a rare manifestation of leukemia relapse during postallograft period
Önal I. K., Shorbagi A., GÖKER H., Büyükasyk Y., ÖZÇAKAR L., Tufan A., et al.
Journal of the National Medical Association
, cilt.98, sa.5, ss.808-810, 2006 (SCI-Expanded, Scopus)
2006
2006150. Over-expression of angiotensin-converting enzyme (CD 143) on leukemic blasts as a clue for the activated local bone marrow RAS in AML
Aksu S., Beyazit Y., Haznedaroglu I. C., Canpinar H., Kekilli M., ÜNER A., et al.
LEUKEMIA & LYMPHOMA
, cilt.47, sa.5, ss.891-896, 2006 (SCI-Expanded, Scopus)
2004
2004151. Synthesis and crystal structure elucidation of 1-(4-fluorobenzyl)-2-(4-cyanophenyl)-1H-benzimidazole-5-carbonitrile
Ozbey S., KAYNAK F. B., GOKER H., KUS C.
JOURNAL OF CHEMICAL CRYSTALLOGRAPHY
, cilt.34, sa.12, ss.851-858, 2004 (SCI-Expanded, Scopus)
2002
2002152. 2-(2,4-Dichlorophenyl)-5-fluoro-6-morpholin-4-yl-1H-benzimidazole monohydrate
Ozbey S., KAYNAK F. B., KUS C., GOKER H.
ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE
, cilt.58, 2002 (SCI-Expanded)
2001
2001153. Crystal structure of 1-cyclopropyl-2-ethyl-5-fluoro-6-(4-methylpiperazin-1-yl)-1H-benzimidazole
Ozbey S., KUS C., GOKER H.
ANALYTICAL SCIENCES
, cilt.17, sa.8, ss.1019-1020, 2001 (SCI-Expanded, Scopus)
1999
1999154. Synthesis and antihistaminic H-1 activity of 1,2,5(6)-trisubstituted benzimidazoles
GOKER H., AYHAN-KILCIGIL G., TUNCBILEK M. G., KUS C., ERTAN R., KENDI E., et al.
HETEROCYCLES
, cilt.51, sa.11, ss.2561-2573, 1999 (SCI-Expanded, Scopus)
1999
1999155. 2,5-dichloro-1-(p-chlorobenzyl)-1H-benzimidazole
KENDI E., Ozbey S., GOKER H.
ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS
, cilt.55, ss.243-245, 1999 (SCI-Expanded, Scopus)
1998
1998156. 1-benzyl-2-(2,6-dichloroanilinomethyl)-1H-benzimidazole
KENDI E., Ozbey S., TUNCBILEK M. G., GOKER H.
ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS
, cilt.54, ss.854-856, 1998 (SCI-Expanded, Scopus)
1998
1998157. The structure of 1-(p-fluorophenylmethyl)-2-(4-methyl-1-piperazinyl)-1H-benzimidazole hydrogen fumarate
Ozbey S., KENDI E., GOKER H., TUNCBILEK M. G.
JOURNAL OF CHEMICAL CRYSTALLOGRAPHY
, cilt.28, sa.6, ss.461-464, 1998 (SCI-Expanded, Scopus)
1997
1997158. 2-(2-ethoxycarbonyl-1,4-benzodioxan-7-yl)-4H-1-benzopyran-4-one
Ozbey S., KENDI E., GOKER H., ERTAN R.
ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS
, cilt.53, ss.1981-1983, 1997 (SCI-Expanded, Scopus)
1995
1995159. Synthesis of some new benzimidazole-5(6)-carboxylic acids
GOKER H., OLGEN S., ERTAN R., AKGUN H., Ozbey S., KENDI E., et al.
JOURNAL OF HETEROCYCLIC CHEMISTRY
, cilt.32, sa.6, ss.1767-1773, 1995 (SCI-Expanded, Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2023
20231. Hematopoetik kök hücre nakli yapılan hastalarda nakil tipine göre yorgunluk düzeyinin karşılaştırılması.
YILDIZ KABAK V., DEMİRCİOĞLU KARAGÖZ A., KUMBAROĞLU F. B., ALADAĞ KARAKULAK E., KARAHAN S., GÖKER H., et al.
9. Ulusal Fizyoterapi ve Rehabilitasyon Kongresi, Denizli, Türkiye, 26 Ekim 2023, (Özet Bildiri)
2019
20192. Proceedings of the World Congress of Gastroenterology
BALABAN H. Y., ASLAN A. T., AKDOĞAN KİTTANA F. N., ALP A., DAĞ O., AYAR Ş. N., et al.
World Congress of Gastroenterology, İstanbul, Türkiye, 21 Eylül 2019, cilt.30, ss.729, (Özet Bildiri)
2019
20193. Incidence and risk factors for hepatic sinusoidal obstruction syndrome after allogeneic transplantation: Retrospective multicenter study of Turkish hematology research and education group (THREG), updated data
SOYER N., Gunduz M., Tekgunduz E., Deveci B., Ozdogu H., ŞAHİN H. H., et al.
45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Frankfurt, Almanya, 24 - 27 Mart 2019, cilt.54, ss.254-255, (Özet Bildiri)
2019
20194. AZACYTIDINE BEFORE ALLOGENEIC STEM CELL TRANSPLANTATION IS INFERIOR TO HD/ARA-C WITHRESPECT TO RELAPSE FOLLOWING TRANSPLANTATION
DEMİROĞLU H., OKAY M., ÇİFTÇİLER R., ALADAĞ KARAKULAK E., GÜL Ö., BÜYÜKAŞIK Y., et al.
24th EHA Congress, 13 - 16 Haziran 2019, cilt.3, ss.941-942, (Özet Bildiri)
2019
20195. THE EVALUATION OF THE CLINICOPATHOLOGIC CHARACTERISTICS OF T-CELL NON-HODGKIN’S LYMPHOMA: THE SINGLE CENTER EXPERIENCE
SAYINALP N., ALADAĞ KARAKULAK E., OKAY M., ÇİFTÇİLER R., AKSU S., DEMİROĞLU H., et al.
15th International Conference on Malignant Lymphoma, İsviçre, 18 - 22 Haziran 2019, cilt.37, ss.366, (Özet Bildiri)
2019
20196. HEMATOLOJİK MALİGNİTELERDE DONÖR LENFOSİT İNFÜZYONU ÖNCESİ VERİLEN KEMOTERAPİ SİKLUS SAYISININ SAĞKALIMA ETKİSİ
ALADAĞ KARAKULAK E., OKAY M., ÇİFTÇİLER R., BÜYÜKAŞIK Y., GÖKER H., DEMİROĞLU H.
4. ULUSAL KAN VE KEMİK İLİĞİ NAKLİ KONGRESİ, Kıbrıs (Kktc), 4 - 06 Nisan 2019, (Özet Bildiri)
2019
20197. ASEMPTOMATİK D-DİMER YÜKSEKLİĞİ İMMÜNMONULATUAR KULLANAN MULTİPLE MYELOMADA TROMBOZU TAHMİN EDER Mİ: GERÇEK YAŞAM VERİSİ
AYDIN M. S., ALADAĞ KARAKULAK E., ÇİFTÇİLER R., YAZGAN S. Ç., DEMİROĞLU H., ÖZCEBE O. İ., et al.
4. ULUSAL KAN VE KEMİK İLİĞİ NAKLİ KONGRESİ, Kıbrıs (Kktc), 4 - 06 Nisan 2019, (Özet Bildiri)
2019
20198. Hematopoietic Stem Cell Transplantation for HIV-positive Patients with Hematologic MAlignancies: Three Patients Experience from Turkey
Çiftçiler R., GÖKER H., İNKAYA A. Ç., ÜNAL S., DEMİROĞLU H.
International Forum on Infectious Diseases, İstanbul, Türkiye, 21 - 24 Mart 2019, ss.11-14, (Tam Metin Bildiri)
2019
20199. MULTİPLE MYELOM HASTALARINDA İNDUKSİYON TEDAVİ SÜRESİNİN SAĞKALIMA ETKİSİ
ALADAĞ KARAKULAK E., OKAY M., ÇİFTÇİLER R., DEMİROĞLU H., AKSU S., BÜYÜKAŞIK Y., et al.
3. HEMATOLOJİK İMMUNOLOJİ KONGRESİ, Türkiye, 8 - 09 Mart 2019, (Özet Bildiri)
2018
201810. Hepatitis E Virus Epidemiology and Genotype Analysis Among Special Risk Groups in Turkey, 16. Ulusal Hepato Gastroenteroloji Kongresi, 17-23 Ekim 2019-Girne, KKTC.
ASLAN A. T., BALABAN H. Y., AYAR Ş. N., AKDOĞAN KİTTANA F. N., ALP A., Vahabov C., et al.
16. Ulusal Hepato Gastroenteroloji Kongresi, Girne, Kıbrıs (Kktc), 31 Ekim 2018, (Özet Bildiri)
2018
201811. Long-Term Results of Non-Fludarabine Versus Fludarabine-Based Conditioning Regimens in Severe Aplastic Anemia Patients
ALADAĞ KARAKULAK E., DEMİROĞLU H., Ciftciler R., BÜYÜKAŞIK Y., SAYINALP N., AKSU S., et al.
60th Annual Meeting of the American-Society-of-Hematology (ASH), California, Amerika Birleşik Devletleri, 1 - 04 Aralık 2018, cilt.132, (Özet Bildiri)
2018
201812. Analysis of Elderly Patients with Chronic Myeloid Leukemia
KELKİTLİ E., GÖKER H., Turgut M., ATAY M. H.
60th Annual Meeting of the American-Society-of-Hematology (ASH), California, Amerika Birleşik Devletleri, 1 - 04 Aralık 2018, cilt.132, (Özet Bildiri)
2018
201813. AĞIR APLASTİK ANEMİ HASTALARINDA HEMATOPOETİK KÖK HÜCRE NAKLİNDE KULLANILAN HAZIRLIK REJİMLERİNİN KARŞILAŞTIRILMASI
ALADAĞ KARAKULAK E., DEMİROĞLU H., ÇİFTÇİLER R., BÜYÜKAŞIK Y., SAYINALP N., AKSU S., et al.
44.ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Türkiye, 31 Ekim - 03 Kasım 2018, ss.261, (Özet Bildiri)
2018
201814. PHİLADELPHİA KROMOZOMU POZİTİF AKUT MYELOİDLÖSEMİLİ OLGU
ÇİFTÇİLER R., ALADAĞ KARAKULAK E., OKAY M., GÖKER H., DEMİROĞLU H., BÜYÜKAŞIK Y.
44. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Türkiye, 31 Ekim - 03 Kasım 2018, ss.340, (Özet Bildiri)
2018
201815. MRG’DE TESADÜFEN SAPTANAN KEMİK İLİĞİNİN DİFFÜZ SİNYAL DEĞİŞİKLİKLERİ LENFOHEMATOPOETİK HASTALIKLARI ÖNGÖREBİLİR Mİ?
ÇİFTÇİLER R., ALADAĞ KARAKULAK E., AKSU S., SAYINALP N., DEMİROĞLU H., GÖKER H., et al.
44. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Türkiye, 31 Ekim - 03 Kasım 2018, ss.266, (Özet Bildiri)
2018
201816. LENALIDOMID İLE MYELOMDA OTOLOG NAKİL SONRASI İLK NÜKSDE TALİDOMİD VE BORTEZOMİBE KIYASLA DAHA İYİ İLERLEMESİZ SAĞKALIM
DEMİROĞLU H., AKSU S., SAYINALP N., GÖKER H., BÜYÜKAŞIK Y., ÖZCEBE O. İ., et al.
TÜRK HEMATOLOJİ DERNEĞİ, Türkiye, 31 Ekim - 03 Kasım 2018, (Tam Metin Bildiri)
2018
201817. T HÜCRELİ LENFOMA HASTALARININ KLİNİK ÖZELLİKLERİNİN DEĞERLENDİRİLMESİ: TANIDAN PROGNOZA TEK MERKEZ DENEYİMİ
DEMİROĞLU H., SAYINALP N., GÖKER H., BÜYÜKAŞIK Y., ÖZCEBE O. İ., HAZNEDAROĞLU İ. C., et al.
TÜRK HEMATOLOJİ DERNEĞİ, Türkiye, 31 Ekim - 03 Kasım 2018, (Tam Metin Bildiri)
2018
201818. PHILADELPHIA KROMOZOMU POZİTİF AKUT MYELOİD LÖSEMİLİ OLGU
DEMİROĞLU H., GÖKER H., BÜYÜKAŞIK Y., ÇİFTÇİLER R., ALADAĞ KARAKULAK E., OKAY M.
TÜRK HEMATOLOJİ DERNEĞİ, Türkiye, 31 Ekim - 03 Kasım 2018, (Tam Metin Bildiri)
2018
201819. DASATİNİB KULLANIRKEN PLEVRAL EFFÜZYONU GELİŞİP, KÜÇÜK HÜCRELİ AKCİĞER KANSERİ TANISI ALAN BİR OLGU
ÇİFTÇİLER R., ALADAĞ KARAKULAK E., SAYINALP N., HAZNEDAROĞLU İ. C., ÖZCEBE O. İ., AKSU S., et al.
44. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Türkiye, 31 Ekim - 03 Kasım 2018, ss.364-365, (Özet Bildiri)
2018
201820. BRENTIXUMAB VEDOTIN IN CD30 LYMPHOMAS: SINGLE CENTER EXPERIENCE
DEMİROĞLU H., SAYINALP N., BÜYÜKAŞIK Y., ÖZCEBE O. İ., HAZNEDAROĞLU İ. C., GÖKER H., et al.
IX. INTERNATIONAL EHOC, 17 - 20 Ekim 2018, cilt.73, (Tam Metin Bildiri)
2018
201821. Extramedullary relapse of the AML following allo-HSCT: a case repor
ÇİFTÇİLER R., ALADAĞ KARAKULAK E., OKAY M., GÖKER H.
IX. International Eurasian Hematology-Oncology Congress, Türkiye, 17 - 20 Ekim 2018, cilt.71, ss.43, (Özet Bildiri)
2018
201822. Mitoxantrone-melphalan conditioning regimen for autologous stem cell transplantation in relapsed/refractory lymphoma
OKAY M., BÜYÜKAŞIK Y., DEMİROĞLU H., MALKAN Ü. Y., CIFTCILER R., Aladag E., et al.
9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 17 - 20 Ekim 2018, cilt.73, (Özet Bildiri)
2018
201823. AKUT MYELOİD LÖSEMİLİ BİR OLGULDA SİTOZİN ARABİNOZİD İLİŞKİLİ PULMONER TOKSİSİTE
ÇİFTÇİLER R., ALADAĞ KARAKULAK E., HAZNEDAROĞLU İ. C., AKSU S., DEMİROĞLU H., GÖKER H., et al.
4.İLAÇ VE TEDAVİ KONGRESİ, Kıbrıs (Kktc), 19 - 23 Eylül 2018, ss.254, (Özet Bildiri)
2018
201824. COMPARISON OF MYELOABLATIVE AND REDUCED-INTENSITY CONDITIONING REGIMENS FOR ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
ÇİFTÇİLER R., OKAY M., ALADAĞ KARAKULAK E., BÜYÜKAŞIK Y., GÖKER H., DEMİROĞLU H.
EUROPEAN HEMATOLOGY ASSOCIATION, 14 - 17 Haziran 2018, (Tam Metin Bildiri)
2018
201825. EFFECT OF THE INDUCTION THERAPY ON SURVIVAL IN MULTIPLE MYELOMA PATIENTS
ALADAĞ KARAKULAK E., ÇİFTÇİLER R., DEMİROĞLU H., AKSU S., BÜYÜKAŞIK Y., HAZNEDAROĞLU İ. C., et al.
The International Congress of BMT 2018, Busan, Güney Kore, 30 Ağustos - 01 Eylül 2018, (Özet Bildiri)
2018
201826. DOES ASYMPTOMATIC D-DIMER ELEVATION PREDICT THROMBOSIS IN PATIENTS ON IMMUNOMODULATORY DRUGS IN MULTIPLE MYELOMA: REAL-LIFE DATA
AYDIN M. S., YAZGAN S. Ç., ALADAĞ KARAKULAK E., ÇİFTÇİLER R., KELKİTLİ E., TURGUT M., et al.
23rd Congress of EHA, Stockholm, İsveç, 14 - 17 Haziran 2018, (Özet Bildiri)
2018
201827. POST-TRANSPLANT EBSTEIN-BARR VIRAL LOAD MONITORING EXPERIENCE IN A HEMATOPOIETIC STEM CELL TRANSPLANTATION CENTER
AYDIN M. S., İNKAYA A. Ç., ALADAĞ KARAKULAK E., ÇİFTÇİLER R., TURGUT M., GÖKER H., et al.
23rd Congress of EHA, Stockholm, İsveç, 14 - 17 Haziran 2018, (Özet Bildiri)
2018
201828. Posttransplant Ebstain-Barr viral load monitoring experience in a hematopoietic stem cell transplantation center
AYDIN M. S., Inkaya Çağkan a., ALADAĞ KARAKULAK E., çiftçiler R., TURGUT M., GÖKER H., et al.
European Hematology Association, 14 - 17 Haziran 2018, (Özet Bildiri)
2018
201829. The Novel Translocation Of T(121) In Multiple Myeloma With Complex Karyotype
OKAY M., ÇİFTÇİLER R., ALADAĞ KARAKULAK E., GÖKER H.
23rd Congress of EHA, Stockholm, İsveç, 14 - 17 Haziran 2018, (Özet Bildiri)
2018
201830. Does Asymptomatic D-Dimer Elevation Predict Thrombosis in Patient on Immunomodulatory Drugs in Multiple Myeloma: Real-Life Data
AYDIN M. S., YAZGAN S. C., ALADAĞ KARAKULAK E., Çiftçiler R., KELKİTLİ E., TURGUT M., et al.
European Hemtology Association, 14 - 17 Haziran 2018, (Özet Bildiri)
2018
201831. RISK FACTORS FOR EARLY MORTALITY IN MULTIPLE MYELOMA WITH DIFFERENT SURVIVAL TIME CUT-OFF POINTS: REAL-LIFE DATA
AYDIN M. S., ALADAĞ KARAKULAK E., ÇİFTÇİLER R., DEMİROĞLU H., GÖKER H., TURGUT M., et al.
23rd Congress of EHA, Stockholm, İsveç, 14 - 17 Haziran 2018, (Özet Bildiri)
2018
201832. ANJİMMUNOBLASTİK T HÜCRELİ LENFOMA, ÇOK YÜZLÜ LENFOMA
OKAY M., ÇİFTÇİLER R., ALADAĞ KARAKULAK E., HEZİYEV T., GÖKER H., BÜYÜKAŞIK Y.
2. HEMATOLOJİK İMMUNOLOJİ KONGRESİ, Kıbrıs (Kktc), 4 - 06 Mayıs 2018, (Özet Bildiri)
2018
201833. PLAZMA HÜCRELİ LÖSEMİ ŞEKLİNDE PREZENTE OLAN WALDENSTROM MAKROGOBULİNEMİSİ
ÇİFTÇİLER R., OKAY M., ALADAĞ KARAKULAK E., HEZİYEV T., AKSU S., SAYINALP N., et al.
2. HEMATOLOJİK İMMUNOLOJİ KONGRESİ, Kıbrıs (Kktc), 4 - 06 Mayıs 2018, (Özet Bildiri)
2018
201834. Common medical problems in adult patients with Hemophilia A: A single center experience
AYDIN M. S., OKAY M., ÇİFTÇİLER R., ALADAĞ KARAKULAK E., DEMİROĞLU H., GÖKER H., et al.
15. INTERNATIONAL HEMOPHILIA CONGRESS OF TURKEY, İstanbul, Türkiye, 4 - 07 Nisan 2018, (Özet Bildiri)
2018
201835. DAMAK TUTULUMU İLE EKSTRAMEDÜLLER NÜKS OLAN RELAPS REFRAKTER MULTİPLE MYELOM OLGUSU
ÇİFTÇİLER R., OKAY M., ALADAĞ KARAKULAK E., DEMİROĞLU H., GÖKER H.
3. ULUSAL KAN VE KEMİK İLİĞİ NAKLİ KONGRESİ, Kıbrıs (Kktc), 29 - 31 Mart 2018, (Özet Bildiri)
2017
201736. Prognosis of Multiple Myeloma in Younger Patients Who Are Undergoing Upfront Autologuous Stem Cell Transplantation
KELKİTLİ E., GÖKER H., DEMİROĞLU H., TURGUT M., OKAY M., SAYINALP N., et al.
LYMPHOMA AND MYELOMA 2017, New York, Amerika Birleşik Devletleri, 26 - 28 Kasım 2017, cilt.1, ss.43-44, (Özet Bildiri)
2017
201737. Donor Lymphocyte Infusions: Single Center Experience
KELKİTLİ E., GÖKER H., TURGUT M., DEMİROĞLU H., SAYINALP N., AKSU S., et al.
LYMPHOMAMYELOMA 2017, New York, Amerika Birleşik Devletleri, 26 - 28 Kasım 2017, cilt.1, ss.48, (Özet Bildiri)
2017
201738. Prognosis of Multiple Myeloma in Younger Patients who Undergoing Upfront Autologous Stem Cell Transplantation
KELKİTLİ E., GÖKER H., demiroglu H., TURGUT M., SAYINALP N., AKSU S., et al.
LYMPHOMA MYELOMA 2017, 26 - 28 Ekim 2017, (Özet Bildiri)
2017
201739. Donor Lymhocyte Infusion: Single Center Experience
KELKİTLİ E., GÖKER H., TURGUT M., Demiroğlu H., SAYINALP N., AKSU S., et al.
LYMHOMA MYELOMA 2017, 26 - 28 Ekim 2017, (Özet Bildiri)
2018
201840. EFFECT OF INDUCTION THERAPY ON SURVIVAL IN MULTIPLE MYELOMA PATIENTS
DEMİROĞLU H., ALADAĞ KARAKULAK E., AKSU S., BÜYÜKAŞIK Y., HAZNEDAROĞLU İ. C., SAYINALP N., et al.
INTERNATIONAL CONGRESS OF BMT 2018, Busan, Güney Kore, 30 Ağustos - 01 Eylül 2018, cilt.53, (Tam Metin Bildiri)
2017
201741. Kemoterapiye refrakter primer mediastinal granülositik sarkom hastasının allojeneik kök hücre transplantasyonu ile tedavisi
ETGÜL S., MALKAN Ü. Y., TURGUT M., DEMİROĞLU H., BÜYÜKAŞIK Y., HAZNEDAROĞLU İ. C., et al.
2. Hematolojik Onkoloji Kongresi, Kıbrıs (Kktc), 16 - 19 Şubat 2017, (Özet Bildiri)
2016
201642. Determination of chemoterapoetic drugsensitivity subgroups of acute leukemia
Türk S., Ghasemi M., malkan Ü. Y., ERİKÇİ A., GÖKER H., HAZNEDAROĞLU İ. C., et al.
The FEBS Journal, 3 - 08 Eylül 2016, (Özet Bildiri)
2016
201643. Determination of chemoterapoetic drug sensitivity subgroups of acute leukemia
TÜRK S., Ghasemi M., MALKAN Ü. Y., Erikci A., GÖKER H., SAYINALP N., et al.
41st FEBS Congress on Molecular and Systems Biology for a Better Life, Kusadasi, Türkiye, 3 - 08 Eylül 2016, cilt.283, ss.373-374, (Özet Bildiri)
2015
201544. AN IGD MYELOMA CASE THAT IS RESISTANT TO CARFILZOMIB
Malkan Ü. Y., GÜNEŞ G., ETGÜL S., HAZNEDAROĞLU İ. C., DEMİROĞLU H., GÖKER H.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)
2015
201545. A COMPOSITE LYMPHOMA CASE
Malkan Ü. Y., GÜNEŞ G., Yayar O., DEMİROĞLU H., GÖKER H., HAZNEDAROĞLU İ. C.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)
2015
201546. SUCCESSFUL TREATMENT OF RESISTANT CHRONIC GRAFT VERSUS HOST DISEASE WITH EXTRACORPOREAL PHOTOPHERESIS IN A PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENT WHO HAS UNDERGONE ALLOGENEIC STEM CELL TRANSPLANTATION
Malkan Ü. Y., GÜNEŞ G., ELİAÇIK E., Yayar O., GÖKER H., ÖZCEBE O. İ.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)
2015
201547. A LATE-ONSET ACUTE GRAFT VERSUS HOST DISEASE CASE WHO IS RESISTANT TO BOTH TACROLIMUS AND CYCLOSPORINE
Malkan Ü. Y., GÜNEŞ G., Aslan T., AKSU S., GÖKER H., HAZNEDAROĞLU İ. C.
6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)
2015
201548. GENERIC IMATINIB MESYLATE IS AS EFFECTIVE AS ORIGINAL GLIVEC IN THE MANAGEMENT OF CML
AKSU S., Aktimur S. H., Arica D. C., Atay H., Bektas O., BÜYÜKAŞIK Y., et al.
20th Congress of European-Hematology-Association, Vienna, Avusturya, 11 - 14 Haziran 2015, cilt.100, ss.690, (Özet Bildiri)
2015
201549. Extramedullary relapses after allogeneic stem cell transplantation for leukemia: Clinical characteristics, cumulative incidence and risk factors
Goker H., Gunes G., Demiroglu H., Malkan Ü. Y., Haznedaroglu I., Sayinalp N., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri)
2014
201450. Prognostic Factors for Survival of Elderly Patients with Acute Myeloid Leukemia after Intensive Chemotherapy: Validation of 3 Popular Prognostic Models
Koca E., Halacoglu A., Malkan Ü. Y., Arica D., Karakus S., GÖKER H., et al.
56th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Kostarika, 6 - 09 Aralık 2014, cilt.124, (Özet Bildiri)
2014
201451. Evaluation of Anti-Neoplastic Effects of a New Hemostatic Agent Ankaferd Blood Stopper on Myeloma Cell Line and Plasmocytoma Development in Balb/c Mice: Results of the First in Vitro and in Vivo Study
Avcu F., Guner M., Misirci M., Elci P., Safali M., GÖKER H., et al.
56th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Kostarika, 6 - 09 Aralık 2014, cilt.124, (Özet Bildiri)
2014
201452. Lower Doses of Plerixafor Use Is Sufficient to Effectively Mobilize PBSC (Peripheral Blood Hematopoetic Stem Cells) When Compared to Standard Administration
GÖKER H., ELİAÇIK E., Altuntas F., Tekgunduz E., ÖZDEMİR E., Isik A., et al.
56th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Kostarika, 6 - 09 Aralık 2014, cilt.124, (Özet Bildiri)
2014
201453. GENERIC IMATINIB MESYLATE IS AS EFFECTIVE AS ORIGINAL GLIVEC IN THE MANAGEMENT OF CML
AKSU S., AKTİMUR S., ARİCA D., ATAY M. H., BEKTAŞ Ö., BÜYÜKAŞIK Y., et al.
20th Congress of the European Hematology Association Vienna, Austria June 11-14,2015, 11 - 14 Haziran 2014, (Tam Metin Bildiri)
2014
201454. High-dose chemotherapy and autologons peripheral blood stein tell (PBSC) transplantation with initt-cryopreserved PBSCs in multiple myeloma
Goker H., Eliacik E., Buyukasik Y., Haznedaroglu I. C., Turgut M., Aksu S., et al.
50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32, (Özet Bildiri)
2013
201355. Philadelphia-positive acute lymphoblastic leukemia in daily practice: A multicenter experience.
Goker H., Tekgunduz E., Sari I., Pala C., Dogu M. H., Ozturk E., et al.
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri)
2012
201256. Laser methods for pharmaceutical pollutants removal
Smarandache A., Militaru A., GÖKER H., Pascu A., Pascu M.
6th Conference on Advanced Topics in Optoelectronics, Microelectronics, and Nanotechnologies (ATOM-N), Constanta, Romanya, 23 - 26 Ağustos 2012, cilt.8411, (Tam Metin Bildiri)
2010
201057. Serological response to influenza vaccine haematopoetic stem cell transplantation patients
YALÇIN Ş., Kondolot M., Albayrak N., Altas B., Karacan Y., KUŞKONMAZ B. B., et al.
36th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantat/9th Meeting of the EBMT Data-Management-Group/26th Meeting of the EBMT Nurses Group/2nd EBMT Qual Management Meeting, Vienna, Avusturya, 21 - 24 Mart 2010, cilt.45, (Özet Bildiri)
2009
200958. Comparison of Low Dose Total Body Irradiation (TBI)-Based Reduced Intensity Conditioning (RIC) Vs. Chemotherapy-Based RIC Prior to Allogeneic Stem Cell Transplantation (allo-SCT) From An HLA Identical Sibling Donor for Acute Myeloid Leukemia (AML) in First Complete Remission (CR1): a Retrospective Analysis of 1200 Patients From the Acute Leukemia Working Party of EBMT.
Mohty M., Labopin M., Janssen J. J. W. M., Mufti G. J., Cornelissen J. J., Milpied N., et al.
51st Annual Meeting of the American-Society-of-Hematology, Louisiana, Amerika Birleşik Devletleri, 5 - 08 Aralık 2009, cilt.114, ss.489, (Özet Bildiri)
2009
200959. Addition of Thalidomide (T) to Oral Melphalan/Prednisone (MP) in Patients with Multiple Myeloma: Initial Results of a Randomized Trial From the Turkish Myeloma Study Group.
BEKSAÇ M., HAZNEDAR R., Firatli-Tuglular T., Ozdogu H., Aydogdu I., Konuk N., et al.
51st Annual Meeting of the American-Society-of-Hematology, Louisiana, Amerika Birleşik Devletleri, 5 - 08 Aralık 2009, cilt.114, ss.746-747, (Özet Bildiri)
2008
200860. Impact of Cytogenetics Risk on Outcome after Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) from An HLA Identical Sibling for Patients with Acute Myeloid Leukemia (AML) in First Complete Remission (CR1)
Mohty M., Labopin M., Milpied N., Cornelissen J. J., Blaise D., Petersen E., et al.
50th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Kostarika, 6 - 09 Aralık 2008, cilt.112, ss.134-135, (Özet Bildiri)
2007
200761. Haemostatic actions of the folkloric medicinal plant extract, Ankaferd Blood Stopper
GÖKER H., HAZNEDAROĞLU İ. C., Ercetin S., Kirazli S., Akman U., Ozturk Y., et al.
49th Annual Meeting of the American-Society-of-Hematology, Georgia, Amerika Birleşik Devletleri, 8 - 11 Aralık 2007, cilt.110, (Özet Bildiri)
Kitaplar
2019
20191. Klinik Pratikte Hematoloji
HAZNEDAROĞLU İ. C., TURGUT M., GÖKER H., BÜYÜKAŞIK Y.
nobel tıp kitabevleri, Ankara, 2019